INTRODUCTION {#SEC1}
============

*Salmonella* is an important facultative pathogen causing food-borne illness and typhoid fever in humans, with a high rate of morbidity and mortality ([@B1]). Flagella in *Salmonella* allow locomotion and are also involved in the invasion process to infect host cells and trigger the host immune system ([@B2],[@B3]). The formation and assembly of the flagellum is a well-organized, hierarchical process in *Salmonella* ([@B4]). Flagellar genes in *Salmonella* are divided into three classes based on the order of transcription ([@B5]). The FlhD~4~C~2~ complex, the only product of the flagellar class I operon, is essential for the expression of other flagellar genes ([@B6]--[@B8]). Four FlhD subunits and two FlhC subunits form the FlhD~4~C~2~ heterohexamer to bind to the DNA upstream of flagellar class II promoters, recruit RNA polymerase, and promote flagellar class II gene transcription ([@B8],[@B9]). Our previous study showed that FlhD~4~C~2~ binds to its target DNA through the FlhC subunit, and FlhD is essential for DNA binding by maintaining the ring-like structure of FlhD~4~C~2~ ([@B10]).

The translation and expression of the *flhDC* operon is tightly regulated by a series of regulators. The AMP-catabolite gene activator protein complex activates flhDC transcription when there is a high intracellular concentration of cAMP ([@B11]). RcsB, H-NS and RtsB also regulate cell motility by interacting with the flhDC promoter ([@B11]--[@B13]). CsrA, an RNA-binding protein, regulates flagellar gene expression by enhancing translation of flhDC mRNA, and DnaK, a chaperone protein, converts the native FlhDC to a functional protein form ([@B14]--[@B16]). The intracellular FlhD~4~C~2~ complex can be degraded by the ClpXP protease ([@B7]). Additionally, three proteins, STM1344 (also named YdiV or RflP), STM1697 and FliT, were recently identified as negative regulators of flagellum in *Salmonella* by direct protein--protein interactions: FliT binds to the FlhC subunit, and STM1344 and STM1697 interact with the FlhD subunit ([@B17]--[@B22]).

STM1344 and STM1697 belong to the EAL-like domain family, whose members are often related to hydrolysis of the second signaling messenger bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) but STM1344 and STM1697 do not exhibit catalytic activity to c-di-GMP or the ability to bind c-di-GMP ([@B17],[@B23],[@B24]). Our previous studies showed that YdiV (*Escherichia coli* homologue of STM1344) formed multiple types of complexes with FlhD~4~C~2~ ([@B10]). YdiV~1~--FlhD~4~C~2~ and YdiV~2~--FlhD~4~C~2~ could bind DNA, but YdiV~3~--FlhD~4~C~2~ and YdiV~4~--FlhD~4~C~2~ did not. The third and fourth YdiV molecules bound to the FlhD~4~C~2~ complex by squeezing into the ring-like structure of FlhD~4~C~2~ between the two internal D subunits. This opened the ring-like structure, causing the complex to lose its DNA-binding ability. Thus, a reasonable model is that YdiV inhibits FlhD~4~C~2~ only at relatively high concentrations ([@B10]).

Interestingly, although both belong to the EAL-like domain family, a variety of clues show that the molecular mechanism by which STM1697 interacts with FlhD and regulates flagellar gene expression is different from that of YdiV. STM1697 shares only low-sequence identity with STM1344 and *E. coli* YdiV (22 and 29%, respectively) ([@B17]). Additionally, key residues (Phe155, Phe168, Phe181 and Ala184) of YdiV in the YdiV--FlhD interface are missing or substituted in the sequence of STM1697, suggesting a novel interactional mode ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). More importantly, results from recent studies have shown that the FlhD~L22H~ mutant disrupts the interaction with YdiV but is still able to interact with STM1697, further indicating distinct interactions of FlhD with STM1697 and YdiV ([@B17]).

Previous findings have demonstrated that STM1697 not only functions as a flagellar regulator but also is involved in virulence phenotypes during Salmonella infection ([@B17]). The deletion of STM1697 promoted *Salmonella* internalization into epithelial cells and the secretion of the type three secretion system 1 effector protein. However, the molecular mechanisms of those regulatory processes remain largely undefined.

Here, we examined the role of STM1697 in the suppression of flagellin production to escape the immune system that occurs when *Salmonella* invades host cells. STM1697 remains a high level after Salmonella enters host cells and restrains the expression of flagellar genes by regulating the function of the flagellar switch protein FlhD~4~C~2~. Unlike other anti-FlhD~4~C~2~ factors, STM1697 could not promote the separation of the FlhD~4~C~2~--DNA complex even at a very high concentration. To better understand the detailed molecular mechanisms for the STM1697-mediated FlhDC regulation, we determined the crystal structure of STM1697--FlhD at 2.0 Å resolution. Structural analysis showed that STM1697 and YdiV bound to the same region of FlhD protein, though the interface of the STM1697--FlhD complex is not as tight as that of YdiV--FlhD. Most importantly, our studies suggested that STM1697 regulates flagellar formation by inhibiting FlhD~4~C~2~ from recruiting RNA polymerase to the promoters of class II flagellar genes rather than by disturbing the interaction between FlhD~4~C~2~ and DNA. Gene knockout and complementation experiments demonstrated that STM1697 regulates flagellar formation and virulence phenotypes through its interaction with FlhD. Interface mutants of STM1697 that specifically perturb the interaction between STM1697 and FlhD eliminated the flagellar inhibition and virulence regulation activities. Our studies provide new insights into the complex regulation of bacterial flagellum and revise our understanding of the inhibition mechanism of the anti-FlhD~4~C~2~ factors.

MATERIALS AND METHODS {#SEC2}
=====================

Construction of Stm1697 knock-out strain {#SEC2-1}
----------------------------------------

The gene disruption mutant of STM1697 was constructed using the lambda Red recombinase system as described previously ([@B25]).

Plasmid construction {#SEC2-2}
--------------------

For *in vivo* study, STM1697 was cloned into the pBAD24 vector. For expression of STM1344, STM1697, stFlhD and stFlhD~4~C~2~ proteins using *E. coli*, the STM1344, STM1697 and stFlhD genes were cloned into the expression vector pGL01, and the entire flhDC operon was cloned into pET21b. The stFlhD gene was also cloned into pET29b without a his-tag for STM1697--stFlhD production. Mutational derivative plasmids of STM1697 were amplified from the above corresponding plasmids using a Site-Directed Mutagenesis system (TransGen biotech, Beijing, China).

Protein expression and purification {#SEC2-3}
-----------------------------------

STM1697 and mutants were expressed in *E. coli* BL21 (DE3) using NZM medium, and then purified by Ni^2+^-NTA affinity column and Superdex 200 successively.

The STM1697--stFlhD complex was obtained by co-expression in *E. coli* BL21 (DE3) in Luria-Bertani (LB) medium as described ([@B10]). The STM1697--stFlhD complex was lysed by trypsin and purified using a Source Q ion exchange column and Superdex 200 chromatography.

The expression and purification of stFlhD~4~C~2~ was executed as described ([@B10]).

Crystallization and structure determination {#SEC2-4}
-------------------------------------------

Crystals of the STM1697--stFlhD complex were grown by hanging drop vapour diffusion at 20°C. The crystallization buffer contained 0.2 M KCl, 0.01 M MgCl~2~, 0.05 M MES pH5.6 and 5% PEG 8000. Diffraction data were collected at the Shanghai Synchrotron Radiation facility (SSRF) beamline BL17u1. The datasets were processed using the HKL2000 software suite. The atomic model was built using Coot and refined using PHENIX. Data collection and structure refinement statistics are summarized in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

Protein pull-down assay {#SEC2-5}
-----------------------

STM1697 and mutants with the his-tag were used as bait protein. FlhD without the his-tag was used as the prey protein.

EMSA experiment {#SEC2-6}
---------------

For the electrophoretic mobility shift assay (EMSA) experiment presented in Figure [4](#F4){ref-type="fig"}, a 49-bp flhB promoter in *Salmonella* was synthesized as the target DNA. Next, 10 pmol DNA was pre-incubated with different ratios of proteins for 10 min. Then samples were separated by a native 5% polyacrylamide gel and stained with Ethidium Bromide and Coomassie brilliant blue.

Size-exclusion chromatography {#SEC2-7}
-----------------------------

For the size-exclusion chromatography (SEC) experiment presented in Figure [4](#F4){ref-type="fig"}, proteins were mixed at the corresponding ratio with concentrations varying between 50 and 200 μM for 10 min at 4°C and then injected for SEC using a superdex 200 column.

For the SEC experiment presented in Figure [6](#F6){ref-type="fig"}, a 145-bp DNA fragment containing the fliA promoter was amplified from the *Salmonella* genome. Polymerase chain reaction (PCR) products were purified using the E.Z.N.A. Cycle Pure Kit (OMEGA). Proteins and DNA were mixed for 10 min at 4°C and then injected for SEC using a Superdex 200 increase column.

Native gel experiment {#SEC2-8}
---------------------

For the native gel experiment shown in Figure [5](#F5){ref-type="fig"}, a 269-bp DNA fragment containing the fliA promoter was amplified from the *Salmonella* genome. PCR products were purified using the E.Z.N.A. Cycle Pure Kit (OMEGA). About 10 pmol DNA was pre-incubated with different ratios of protein. Then, the samples were separated by native 4% polyacrylamide gel and stained with Gel Red and Coomassie brilliant blue G250.

Preparation of strains used in functional studies {#SEC2-9}
-------------------------------------------------

*Salmonella typhimurium* ATCC14028 and mutant strains were grown overnight in 10 ml LB medium with 100 μg/ml Ampicillin, and then subcultured into 5 ml LB medium with 100 μg/ml Ampicillin and 0.1% L-arabinose to induce protein expression. To induce invasion phenotype, LB + 0.3M NaCl were used to culture bacteria. When the OD600 reached 0.4--0.6, all strains were adjusted to the same OD600 by the addition of 0.9% NaCl. Bacterial cells were then harvested for functional study. The detailed information of strains used in this study are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.

Cell culture, bacterial infection model and RNA extraction {#SEC2-10}
----------------------------------------------------------

The human colon adenocarcinoma cell line HT-29 was maintained at 37°C in a humidified atmosphere with 5% CO~2~ in complete RPMI-1640 medium (Gibco) containing 10% fetal bovine serum (Gibco). Cells were seeded at 1 × 10^7^ in 100-mm-wide tissue culture dishes. *Salmonella typhimurium* ATCC14028 and the STM1697 knock-out strain were added to the HT-29 cell monolayer at an Multiplicity Of Infection (MOI) = 10. After 1 h at 37°C, 100 μg ml^−1^ gentamicin was added to the cells to kill the extracellular bacteria. At each time point, 2, 4, 6 and 8 h after infection, the HT-29 monolayers were washed, lysed in TRIzol reagent (TIANGEN) and then stored at −70°C.

RNA isolation and real-time quantitative PCR {#SEC2-11}
--------------------------------------------

Total RNA was isolated using the RNAprep Pure Cell/Bacteria Kit (TIANGEN). The reverse transcription reactions were performed using the RevertAid cDNA Synthesis Kit (Thermo) according to the manufacturer\'s instructions. The quantitative real-time-PCR (qRT-PCR) reactions were performed on an Applied Biosystems 7500 Sequence Detection system (Applied Biosystems, Foster, CA, USA) using iTaq Univerial SYBR Green Supermix (BIO-RAD).

Western blot {#SEC2-12}
------------

Bacterial cells were lysed and examined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Polyclonal antibody of FliC (abcam) and HRP-Conjugated Goat anti Rabbit IgG (h+l) (abcam) were used in this study.

Swimming motility assay {#SEC2-13}
-----------------------

Bacterial cells were diluted to OD600 = 10 and inoculated on 0.3% LB agar plates with 100 μg/ml Ampicillin and 0.1% L-arabinose. Swimming motility was observed after 5 h at 30°C.

Invasion assay {#SEC2-14}
--------------

For the experiments in Figure [7](#F7){ref-type="fig"}, Bacteria were diluted using RPMI-1640 medium and then seeded on confluent HT-29 cells grown in 24-well plates at a multiplicity of infection of 20. One hour post-infection, gentamicin (100 μg ml^−1^) was added to the cells for 1 h to kill the remaining extracellular bacteria. Cells were washed gently with phosphate-buffered saline and then disrupted with 1% Triton X-100 (Sigma Chemical). The number of intracellular bacteria was determining the colony-forming units (CFU) counts of viable colonies.

Macrophage cytotoxicity assay {#SEC2-15}
-----------------------------

Bone marrow-derived macrophages were isolated as described. Macrophages were infected at the indicated MOI and then incubated for 4 h. Cytotoxicity was determined by LDH assay (CytoTox 96, Promega). IL-1β and IL-18 secretion was determined by ELISA kit (R&D Systems and MBL, respectively).

In vivo infection of BALB/c mice {#SEC2-16}
--------------------------------

Six- to eight-week-old female BALB/c mice were used in this study. For bacterial infections, mice were infected intraperitoneally (IP) with 1 × 10^6^ of each *S. typhimurium* strain. The mice were sacrificed 6 h post-infection. The number of bacteria located in the spleen or liver was detected by CFU counts of viable colonies. For survival, each cohort of mice (*n* = 5) was infected intraperitoneally with 1 × 10^6^ bacteria in 100 μl, and the death of mice were observed every 2--3 h.

RESULTS {#SEC3}
=======

*Salmonella* upregulates STM1697 expression during invasion {#SEC3-1}
-----------------------------------------------------------

The intracellular expression of STM1697 before and after *Salmonella* entering into host cells was monitored by qRT-PCR (Figure [1A](#F1){ref-type="fig"}). Compared with the one before invasion, the expression of STM1697 increased 11.2-, 40.8- and 65.5-times when detected respectively in 2, 4 and 8 h after invasion. These data suggest that STM1697 may play an important regulatory role when *Salmonella* survive in the host cells.

![STM1697 effectively restrains flagellin expression within host cells. (**A**) Salmonella upregulates STM1697 expression during invasion. The intracellular concentrations of STM1697 mRNA before and after *Salmonella* invasion were detected by qRT-PCR. \*\*\**P* \< 0.001 as compared with the one before invasion (0 h) using a *t*-test. (**B**--**D**) The expression of *fliC, fliA* and *fliZ* genes in wild-type *Salmonella* and △*stm1697* strain before and after they enter into host cells was monitored by qRT-PCR. Statistical significance is indicated by \**P* \< 0.05 and \*\*\**P* \< 0.001 as compared with wild-type strain at the same time using a *t*-test.](gkx656fig1){#F1}

STM1697 is essential for flagellar inhibition during invasion {#SEC3-2}
-------------------------------------------------------------

To investigate the role of STM1697 on expression of flagellar genes during invasion, the expression of *fliC, fliA, fliZ* and *flhD* genes in wild-type *Salmonella* and △*stm1697* strain before and after entering to host cells was monitored by qRT-PCR (Figure [1B](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}; [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Interestingly, in wild-type *Salmonella*, the expression of flagellin (FliC) decreased 2- to 3-fold after invasion while the expression of Class II flagellar genes (FliA and FliZ) increased 3- to 5-fold. In contrast, the expression of FliC, FliA and FliZ in △*stm1697* strain was drastically increased (∼8× for FliC and 40--50× for FliA and FliZ) 8 h post-invasion suggesting some signals of host cells may trigger the high expression of flagellin, and STM1697 effectively restrains flagellin expression to a low level. The mRNA level of the flagellar master gene flhD was not significantly different in the wild-type *Salmonella* and the △*stm1697* strain implying that the inhibition of flagella mediated by STM1697 is realized after transcription of FlhDC.

STM1697 formed stable complexes with FlhD~4~C~2~ but did not prevent FlhDC from binding to DNA {#SEC3-3}
----------------------------------------------------------------------------------------------

STM1697 has been reported to interact with FlhD~4~C~2~ ([@B17]). We found that STM1697 did form stable complexes with FlhD or FlhDC and STM1697--FlhD and STM1697--FlhDC complexes represent good properties in SEC. However, the molecular mechanism of STM1697 mediated flagellar inhibition remained unclear. As described before, interactions of FlhD with STM1697 and YdiV seem to be different. Therefore, one of the goals of our research was to determine the details of the interaction of STM1697 and FlhD~4~C~2~ to better understand their activity.

To determine whether STM1697 inhibits the DNA-binding activity of FlhD~4~C~2~, we performed a series of EMSAs. STM1344 was used as a positive control of a protein that inhibits FlhD~4~C~2~ binding to DNA. Interestingly, the purified STM1697 protein did not effectively inhibit the DNA binding activity of FlhD~4~C~2~ even if the molar ratio of STM1697:FlhDC was as high as 18:1. In contrast, purified STM1344 protein prevented FlhDC from binding to DNA at a ratio of STM1344:FlhDC of 3:1 or higher (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}).

![STM1697 did not prevent FlhD~4~C~2~ from binding to DNA. (**A**) EMSA with stFlhD~4~C~2~ and its target DNA at different concentrations of STM1697. Sixty picomoles of FlhD~4~C~2~ was mixed with different ratios of STM1697 and then the DNA-binding ability was examined by EMSA using 10 pmol DNA. The upper and lower pictures show the same gel stained with ethidium bromide and Coomassie brilliant blue, respectively. (**B**) EMSA with stFlhD~4~C~2~ and its target DNA at different concentration of STM1344. Sixty picomoles of FlhD~4~C~2~ was mixed with different ratios of STM1344 and then the DNA-binding ability was examined by EMSA using 30 pmol DNA. (**C**) EMSA of the stFlhD~4~C~2~-STM1697 mixture and purified STM1697--FlhDC complex. Hundred picomoles of purified STM1697--FlhD~4~C~2~ or STM1697 and FlhD~4~C~2~ mixture (premix for 10 min) were mixed for 10 pmol DNA and examined by EMSA.](gkx656fig2){#F2}

In Figure [2A](#F2){ref-type="fig"}, STM1697, FlhD~4~C~2~ and DNA were added to the reaction system simultaneously. It is possible that the formation of FlhDC and DNA complex in reaction system might be prior to the formation of STM1697 and FlhDC which might be the reason for the negative result. So another EMSA experiment was performed in which STM1697 and FlhDC was mixed at first and then target DNA was added. Purified STM1697--FlhDC complex was also test to further verify that STM1697--FlhDC complex can still bind to DNA (Figure [2C](#F2){ref-type="fig"}). Results showed that premixing of STM1697 and FlhDC and purified STM1697--FlhD~4~C~2~ complex all exhibited DNA binding activity demonstrating that STM1697 does not prevent FlhD~4~C~2~ from binding to DNA, even at high concentration, unlike its homologue YdiV.

Structure of the STM1697--FlhD complex {#SEC3-4}
--------------------------------------

In order to elucidate the interactional mechanism between STM1697 and FlhD~4~C~2~, we crystallized the STM1697--FlhD complex. The crystals diffracted to about 2.0 Å resolution and belonged to space group P31 with the unit-cell parameters of a = b = 61.01Å, c = 166.89 Å, α = β = 90° and γ = 120° ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Surprisingly, structural analysis showed that STM1697 bound to the same region of FlhD (the first and fourth α helix) that YdiV binds (Figure [3A](#F3){ref-type="fig"}). Eleven residues of STM1697 (Val115, Leu116, Leu136, Val147, Phe160, Lys167, Leu172, Leu173, Lys175, His176 and Tyr180) directly participate in the interaction with FlhD, forming a close interface through hydrophobic and electrostatic interactions. Remarkably, Phe160 and Leu173 of STM1697 are located in the center of the molecular interface penetrating into hydrophobic pockets of FlhD with their hydrophobic side chains. Additionally, three pairs of polar contacts (Lys167**^S^**/Glu62**^F^**, Lys175**^S^**/Asp15**^F^** and His176**^S^**/Asp15**^F^**) further strengthen this interface (Figure [3B](#F3){ref-type="fig"}). Mutagenesis was next employed to validate the importance of residues of STM1697 located in the protein-protein interface in the structural model. Eight mutants of STM1697 were constructed and their ability to bind FlhD was investigated using pull-down assays (Figure [3C](#F3){ref-type="fig"}). The binding affinity of the STM1697 F160S mutant to FlhD was significantly decreased, and two mutants (F160A/L173A and L172A/L173A/H176A) lost their affinity to FlhD, confirming the significance of these residues in FlhD-binding.

![Structure of the STM1697--stFlhD complex. (**A**) Schematic diagram of essential residues denoting molecular interactions between STM1697 or YdiV and FlhD. Van der Waals interactions (\<4 Å) and polar interactions (hydrogen bonds or salt bridges) are indicated using solid arrows and dashed arrows, respectively. (**B**) The interface between STM1697 and stFlhD. Residues in the interface are shown in stick model and labeled in relevant color (purple: STM1697, white: stFlhD). (**C**) Pull down of stFlhD by native/mutants of STM1697 with the His-tag. stFlhD without the his-tag was used as the negative control. The two mutants of STM1697 lose interaction with stFlhD. (**D**) CLUSTALW alignment between *Salmonella* STM1697 and STM1697 from other bacteria. Forty residues (160--200 aa) of STM1697 are used in this alignment and the most conserved residues of STM1697 are marked by arrowheads. Cf: *Citrobacter freundii*, En: *Enterobacter* sp. GN02600, Pg:*Pluralibacter gergoviae*, Ec: *Enterobacter cloacae*, Es: *Escherichia coli*, Pr: *Proteobacteria*, Kl: *Klebsiella oxytoca*, Kp: *Klebsiella pneumoniae* and Cr: *Cronobacter sakazakii*.](gkx656fig3){#F3}

By sequence alignment, we found that the key residues (Phe160 and Leu173) of STM1697 in the interactional surface are highly conserved across its orthologs, suggesting this binding interaction of STM1697--FlhD may be employed widely (Figure [3D](#F3){ref-type="fig"}).

Structural comparison between STM1697--FlhD and YdiV--FlhD {#SEC3-5}
----------------------------------------------------------

Structural analysis suggested a topological structure of STM1697 of a modified TIM-like barrel fold similar to that of a conventional EAL domain protein, but with low-sequence identities. Structural comparison of STM1697 with all other PDB entries using the Dali server (<http://ekhidna.biocenter.helsinki.fi/dali_server>) indicated that, as expected, YdiV was the most similar homolog with a root mean square deviation (RMSD) of ∼2.0 Å for 235 Cα atoms. Additionally, we superimposed the STM1697 molecule from the STM1697--FlhD structure and the YdiV molecule from the YdiV--FlhD structure and found that most of regions from STM1697 fit well with those of YdiV except in the region involved in FlhD-binding (Figure [4A](#F4){ref-type="fig"}). When the superposition was performed using FlhD as a template, surprisingly, STM1697 did not match YdiV at all due to position deviation of the entire molecule (Figure [4B](#F4){ref-type="fig"}). The square deviation of the two FlhD-binding helixes (α8 in YdiV and α7 in STM1697) was about 4.6 Å, suggesting that the bond strength of YdiV--FlhD and STM1697--FlhD might be discrepant. Detailed analysis showed that the conformation of FlhD from STM1697--FlhD was almost the same as the one from YdiV--FlhD except the side chain deflection of essential residues (Tyr14 and Lys26) located in the interface of STM1697--FlhD (Figure [4C](#F4){ref-type="fig"}).

![Structural comparison of STM1697--stFlhD and YdiV--mgFlhD. (**A**) Structural superposition of STM1697 and YdiV. The two structures are shown in cartoon mode (YdiV: light yellow, STM1697: green). The FlhD binding sites for STM1697 and YdiV are indicated by circles. (**B**) Structural superposition of STM1697--stFlhD and YdiV--FlhD. The stFlhD in the STM1697--stFlhD structure is used as the reference structure and YdiV-FlhD is superimposed onto the STM1697--stFlhD complex (stFlhD: blue, mgFlhD: light blue, YdiV: light yellow, STM1697: green). (**C**) Details of changes in the stFlhD and mgFlhD (stFlhD from *Salmonella typhimurium*, mgFlhD from *Escherichia coli* MG1655) in the complex structure. Residues located in the interface are shown in stick mode with different colors (stFlhD: hotpink, mgFlhD: blue). The positional changes of the side-chains of 14Y and 26R are indicated by arrows. (**D**) The structure of FlhD~4~C~2~ is used as a model, and STM1697--stFlhD and YdiV--FlhD are separately superimposed onto the third FlhD molecule of FlhD~4~C~2~ (STM1697: orange, YdiV: yellow, FlhD: blue). Whole structures are shown in cartoon mode. The right figure presents a close-up view of the interface between the second and the third FlhD molecules of FlhD~4~C~2~. All interfaces are overlapped, and the interface of YdiV--FlhD shows more interactions than STM1697--stFlhD and D2--D3. (**E**) STM1697 and FlhD~4~C~2~ cannot form the (STM1697)~4~ FlhD~4~C~2~ hetero-decamer. Size-exclusion chromatography (SEC) results of the 2:1 and 5:1 mixtures of STM1697 and FlhD~4~C~2~. The STM1344 and FlhD~4~C~2~ mixture is used as a positive control because it forms the (STM1344)~4~ FlhD~4~C~2~ hetero-decamer *in vitro*. FlhD~4~C~2~ alone is used as another control. The elution volume of every peak value is marked in the corresponding colors. STM1697~2~FlhD~4~C~2~ complex appeared in solution, but no hetero-decamer formed when the ratio of STM1697 and FlhD~4~C~2~ reached 5:1. The right figure presents the model of the STM1697~2~FlhD~4~C~2~ hetero-hexamer.](gkx656fig4){#F4}

Previous study showed that YdiV forms four kinds of complexes with FlhD~4~C~2~: YdiV~1~FlhD~4~C~2~, YdiV~2~FlhD~4~C~2~, YdiV~3~FlhD~4~C~2~ and YdiV~4~FlhD~4~C~2~ ([@B10]). In order to form YdiV~3~FlhD~4~C~2~ and YdiV~4~FlhD~4~C~2~ complexes, YdiV must enter the ring-like structure of FlhD~4~C~2~, disrupting the interface between the central FlhD subunits. As a result, the ring-like structure of FlhD~4~C~2~ is disrupt and the structure of complex rearrange into an opened one that can not bind DNA. To analyze the interaction of those complexes, STM1697--FlhD and YdiV--FlhD were separately superimposed with the central FlhD subunits (D3) of FlhD~4~C~2~. It is evident that the distance between STM1697 and FlhD molecule was furthest, compared with that of YdiV--FlhD and FlhD~2~--FlhD~3~ complexes, suggesting the weakest interaction between STM1697 and FlhD (Figure [4D](#F4){ref-type="fig"}). According to above analysis, whether STM1697 can squeeze into the ring-like structure of FlhD~4~C~2~, as its homologue YdiV, remains uncertain.

STM1697 cannot form STM1697~3~FlhD~4~C~2~ or STM1697~4~FlhD~4~C~2~ complexes with FlhD~4~C~2~*in vitro* {#SEC3-6}
-------------------------------------------------------------------------------------------------------

We next performed experiments using SEC to determine if STM1697 can bind FlhD~4~C~2~ to form STM1697~3~FlhD~4~C~2~ or STM1697~4~FlhD~4~C~2~ complexes. Purified STM1697 protein (26.5 kD) was mixed with FlhD~4~C~2~ protein (96.4 kD) at molar ratios of 5:1 or 2:1 and analyzed by a size-exclusion column. As a control, a 5:1 mixture of STM1344 (26.4 kD) and FlhD~4~C~2~ was used, and should form a stable hetero-decamer (STM1344~4~FlhD~4~C~2~) in solution. FlhD~4~C~2~ alone was also examined as a control. As shown in Figure [4E](#F4){ref-type="fig"}, the STM1697--FlhD~4~C~2~ mixture with the molar ratio of 2:1 showed a single elution peak at a position (13.73 ml) consistent with a larger complex than the FlhD~4~C~2~ hexamer (15.51 ml), suggesting the STM1697--FlhD~4~C~2~ complex formed in solution. When the ratio of STM1697 and FlhD~4~C~2~ was increased to 5:1, two peaks (13.69 and 16.30 ml) appeared. The first peak was the newly-formed STM1697--FlhD~4~C~2~ complex and the second one was the excessive amount of free STM1697. The 5:1 mixture of STM1344 and FlhD~4~C~2~ eluted at two positions, 12.76 and 16.15 ml. The elution volume measured in the 2:1 STM1697--FlhD~4~C~2~ mixture (13.69 ml) was similar to that for the 5:1 mixture (13.73 ml), and were both larger than that of STM1344~4~FlhD~4~C~2~ (12.76 ml), suggesting that STM1697 cannot form the STM1697~3~FlhD~4~C~2~ or STM1697~4~FlhD~4~C~2~ complex with FlhD~4~C~2~ under these conditions. Given the above-mentioned data, we propose that unlike STM1344, STM1697 interacts with FlhD~4~C~2~ to form STM1697~1~--FlhD~4~C~2~ or STM1697~2~--FlhD~4~C~2~ complex, but does not prevent FlhD~4~C~2~ from binding to target DNA.

The binding of STM1697 to FlhD~4~C~2~ restrains RNA polymerase recruitment {#SEC3-7}
--------------------------------------------------------------------------

Previous studies showed that class II flagellar genes are only transcribed by σ^70^-containing RNA polymerase in the presence of the FlhD~4~C~2~ complex ([@B26],[@B27]). The FlhD~4~C~2~ complex binding sites are located ∼30--80 bp upstream of the transcription start site of class II flagellar genes ([@B28],[@B29]). Here, the upstream sequence of *fliA* operon was used to study the transcription initiation of class II flagellar genes. There is no obvious −35 promoter element (TTGACA) in the upstream sequence of the *fliA* operon. At this promoter, the −30 to −79 bp contain the FlhD~4~C~2~ binding site ([@B28],[@B30]). This positioning and the lack of a strong −35 promoter element suggest that FlhD~4~C~2~ may promote σ^70^ RNA polymerase recruitment (Figure [5A](#F5){ref-type="fig"}). The C-terminal domain of the RNA polymerase α subunit was reported to be required for FlhD~4~C~2~-mediated transcription activation and structural simulation showed that FlhD~4~C~2~ was able to directly interact with the α subunit and δ subunit ([@B27]). Therefore, we hypothesize that, when STM1697 binds to the FlhD subunits of the FlhD~4~C~2~ complex, steric exclusion prevents σ^70^ RNA polymerase from binding to template DNA, thus blocking transcription(Figure [5B](#F5){ref-type="fig"}). To test our hypothesis, we examined the ability of RNA polymerase to bind a 269-bp fragment of promoter DNA by native gel electrophoresis (Figure [5A](#F5){ref-type="fig"}, [C](#F5){ref-type="fig"}--[E](#F5){ref-type="fig"}). The results showed that σ^70^ RNA polymerase could not form a complex with target DNA in the absence of the FlhD~4~C~2~ complex. Once FlhD~4~C~2~ was added, FlhD~4~C~2~, RNA polymerase and target DNA formed a large complex (band A in Figure [5C](#F5){ref-type="fig"}--[E](#F5){ref-type="fig"}). Interestingly, upon addition of the anti-factors of FlhD~4~C~2~ (YdiV, STM1344 or STM1697), the large DNA--proteins complex disappeared (Figure [5C](#F5){ref-type="fig"}--[E](#F5){ref-type="fig"}). These data support our hypothesis that the binding of anti-factors (YdiV or STM1697) to the periphery of the FlhDC complex prevents RNA polymerase from binding to the promoter.

![The binding of STM1697 to FlhD~4~C~2~ restrains RNAP recruitment. (**A**) Sequence analysis of the upstream region of the class II flagellar gene *fliA*. The FlhD~4~C~2~ binding region is highlighted in purple, and the −10 like region of the promoter that serves as a σ^70^ RNA polymerase binding site is colored green. The transcriptional start site is marked in red. The endpoints of the 269 bp DNA used for the following experiments is also shown. (**B**) Upper: FlhD~4~C~2~ complex interacts with target DNA through the Zn-cys cluster and the positive-charge-enriched region of the FlhC dimer. After binding to the −30 to −70 region of the target gene, the FlhD~4~C~2~ complex recruits RNA polymerase to form a transcription initiation complex, then the transcription of class 2 flagellar genes is turned on. Lower: the STM1697 molecules bind to two peripheral FlhD subunits to form three-protein complexes with FlhD~4~C~2~. The incorporation of STM1697 prevents RNA polymerase from binding the promoter. As a result, the subsequent expression of flagellar genes is repressed. (**C**--**E**) Native gel results preformed with different ratios of protein mixture. Twenty picomoles of FlhD~4~C~2~, 10 pmol of DNA and 40 pmol of RNAP were used in the reaction systems. Different amounts of YdiV, STM1344 or STM1697 were added according to the indicated ratio to FlhD~4~C~2~. The upper and lower pictures show the same gel stained with Coomassie brilliant blue and Gel red, respectively. Band A is the complex of RNAP, FlhD~4~C~2~ and DNA, and band B contains FlhD~4~C~2~ and DNA. When YdiV, STM1344 or STM1697 were added, band A disappeared.](gkx656fig5){#F5}

SEC was used to further determine that STM1697 promotes dissociation of FlhDC--RNAP--DNA complex. The mixtures of FlhD~4~C~2~, RNAP and DNA in absence and presence of STM1697 were detected. RNAP alone is used as a control (Figure [6](#F6){ref-type="fig"}). FlhDC--RNAP--DNA mixture (∼600 kD) and RNAP (∼500 kD) alone were eluted at the similar position (8.6--8.9 ml). When STM1697 was added to the complex, a second peak appeared at 13.14 ml which might be the complex of STM1697--flhDC--DNA (∼180 kD). Excessive STM1697 was eluted at 16.1--16.4 ml.

![STM1697 promotes dissociation of FlhDC--RNAP--DNA complex. SEC of the mixtures of FlhD~4~C~2~, RNAP and DNA with different concentration of STM1697 were performed. RNAP alone is used as a control. The elution volume of every peak value is marked in the corresponding colors. The cartoon models of protein complexes eluting in corresponding volume were represented below.](gkx656fig6){#F6}

Those results well support our hypothesis that STM1697 prevents σ^70^ RNA polymerase from binding to template DNA.

The STM1697 suppression of cell motility is mediated by its interaction with FlhD {#SEC3-8}
---------------------------------------------------------------------------------

Five *Salmonella* strains containing wild-type, stm1697 knockout strain, or that strain with over-expression of STM1697 or two mutants of STM1697 shown above to be defective in FlhD binding (FlhD-free, Mut-1: F160A/L173A and Mut-2: L172A/L173A/H176A) were constructed for functional study. The STM1697 mutants expressed by Mut-1 and Mut-2 were unable to bind to FlhD *in vitro*, as shown above. High-level expression of native STM1697 or mutant proteins was detected at the RNA level by qRT-PCR and at the protein level by SDS-PAGE ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). To evaluate the transcription levels of flagellar genes in those strains, qRT-PCR was performed of three flagellar genes (*fliA, flhB* and *fliC*). The transcription of all three genes was significantly decreased in the STM1697-expression strain and upregulated in △*stm1697*, compared with the WT strain. Differently, the two STM1697 mutant strains did not show obvious variation compared with the △*stm1697* strain. Those data indicated that STM1697 directly represses class II and class III flagellar genes and this inhibitory effect depends on its interaction with FlhD (Figure [7A](#F7){ref-type="fig"}--[C](#F7){ref-type="fig"}). Subsequently, the expression of FliC protein in those strains was detected by western blotting, and the protein levels were consistent with the qRT-PCR results ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). Next, the motility behavior of those strains was determined using soft agar plates. In accordance with the report from Ahmad *et al.*, the strain deleted for STM1697 exhibited significantly enhanced swimming capability compared to the wild-type strain, and the strain in which STM1697 was over-expressed did not swim at all ([@B17]). The expression of the FlhD-free mutants of STM1697 showed similar motility phenotypes as the △*stm1697* strain suggesting that the motility inhibition of STM1697 is directly mediated by interaction with FlhD (Figure [7D](#F7){ref-type="fig"}). These data supported a model in which the suppression of cell motility by STM1697 was mediated by its interaction with FlhD.

![The suppression of STM1697 of cell motility and virulence phenotypes is mediated by its interaction with FlhD. (**A**--**C**) The expression levels of flagellar gene *fliA, fliZ* and *fliC* in the wild*-*type strain, the STM1697 knockout strain and the STM1697 or mutant over-expressed strains were separately tested by qRT-PCR. GADPH was used as an internal reference. (**D**) The motility of the wild-type strain, the STM1697 knockout strain and STM1697 or mutant over-expressed strains were measured on a 0.3% soft agar plate. (**E**) Invasion capability of those strains for HT-29 cells. (**F**) Bone marrow-derived macrophages (BMDM) from BALB/c mice were infected by the strains. Cytotoxicity was determined by LDH release 4 h post-infection. (**G** and **H**) IL-1βor IL-18 secretion of BMDM infected with MOI 100:1 were determined by ELISA after 4 h post-infection. (**I**) Model illustrating the mechanism of STM1697-mediated invasion and virulence regulation. (**J** and **K**) BALB/c mice were infected with equal numbers of those strains by intraperitoneal injection. CFU in the spleen and liver were determined after 6 h. (**L**) BALB/c mice were infected with equal numbers of the wild-type strain, the STM1697 knockout strain, and over-expressed STM1697 or mutant strains by intraperitoneal injection. Survival was monitored. Bars represent data from three independent experiments. Statistical significance is indicated by \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 as compared with wild-type *Salmonella typhimurium* ATCC14028 using a *t*-test. WT: *S. typhimurium* ATCC14028 VC; Δ1697: Δstm1697 VC; Δ1697p1697: Δstm1697p1697; Δ1697pM1: Δstm1697pM1; Δ1697pM2: Δstm1697pM2. VC = pBAD24, p1697 = STM1697 cloned into pBAD24, pM1 = STM1697 F160A, L173A cloned into pBAD24 and pM2 = STM1697 L172A, L173A, H176A cloned into pBAD24. In all experiments, protein expression was monitored by qPCR and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (see [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}).](gkx656fig7){#F7}

The effect of STM1697 on virulence phenotypes is also mediated by its interaction with FlhD {#SEC3-9}
-------------------------------------------------------------------------------------------

The STM1697 protein was reported to be involved in virulence phenotypes during *Salmonella* infection ([@B17]). To better understand the mechanism by which STM1697 regulates virulence phenotypes of *Salmonella*, the effect of STM1697 and mutants on virulence phenotypes was investigated. First, the ability to invade HT-29 cells was measured for the five strains (Figure [7E](#F7){ref-type="fig"}). Consistent with previous studies, the invasion ability of the △stm1697 strain was enhanced compared with the wild-type strain ([@B17]). Remarkably, the STM1697 over-expression strain showed a defect in invasion of HT-29, as did the two FlhD-free STM1697 mutants, indicating that the ability of STM1697 to regulate invasion phenotypes requires FlhD.

Next, macrophage cytotoxicity of these strains was determined through measurement of lactate dehydrogenase (LDH) release, indicating cell membrane damage. The release of the IL-1β and IL-18 cytokines was also measured using an ELISA kit (Figure [7F](#F7){ref-type="fig"}--[H](#F7){ref-type="fig"}). The release of LDH, IL-1β and IL-18 in the △stm1697 strain was weakly increased compared with the wild-type strain. In contrast, when STM1697 was over-expressed, there was a significant reduction in the levels of LDH, IL-1β and IL-18. The two FlhD-free STM1697 mutants over-expressed strains show similar phenotype as the △stm1697 strain. The above data revealed that the expression of STM1697 can significantly reduce *Salmonella*-caused pyroptosis of macrophages and result in immunosuppression, and these activities require interaction with FlhD. Previous study has shown that the class II flagellar gene FliZ regulates the *Salmonella* pathogenicity island 1 by the activation of HilD and HilA ([@B31],[@B32]). Therefore, the mechanism by which STM1697 regulates invasion and macrophage cytotoxicity in *Salmonella* may be achieved by the inhibition of the FliZ gene (Figure [7I](#F7){ref-type="fig"}).

To investigate the affect of STM1697 on *Salmonella* virulence *in vivo*, animal experiments were conducted (Figure [7J](#F7){ref-type="fig"}--[L](#F7){ref-type="fig"}). The *Salmonella* strain lacking STM1697 showed significantly attenuated ability to colonize the spleen and in the liver when infected intraperitoneally. Interestingly, the multiplication of the STM1697 over-expressed strain in the liver and the spleen were irregular for unknown reasons, and the FlhD-free STM1697 mutant over-expressed strain behaved similarly. Consistent with this observation, the survival curve of mice infected with equal amount of bacteria revealed that the pathogenicity of the △stm1697 strain and the FlhD-free STM1697 mutant over-expressed strain were weaker than wild-type, and the STM1697 over-expressed strain exhibited enhanced virulence. These results indicated that the effect of STM1697 on virulence phenotypes was also mediated by its interaction with FlhD.

DISCUSSION {#SEC4}
==========

The flagellum is indispensable when *Salmonella* is invading host cells, however, after entering host cells, the situation changes. Flagellin can be detected by the host pattern recognition receptor TLR5, which activates the host immune system and triggers pyroptosis of macrophages ([@B33],[@B34]). Interestingly, maybe due to long-term evolution, *Salmonella* reduced the expression of flagellin to escape from the host immune system ([@B35],[@B36]). However, the mechanism involved in this process remains ill-defined. Here, we revealed that the EAL-like protein STM1697 suppressed the formation of flagellum after *Salmonella* invasion into host cells. Significantly, the intracellular concentration of STM1697 increased dozens of times after entering host cells. Very surprisingly, we found that the expression of flagellin increased ∼10× in the △stm1697 strain after entering into host cells, indicating that some signals in host cells may trigger the high expression of flagellin. STM1697 effectively restrains flagellin expression to a low level and avoids detection of *Salmonella* by the host immune system. Thus, a new model by which STM1697 regulates flagellar biogenesis during invasion and infection was established (Figure [8](#F8){ref-type="fig"}).

![The role of STM1697 in the *Salmonella* infection process. Before entry into the host cell, the expression of STM1697 remains at a low level. FlhD~4~C~2~ complex binds to the upstream region of flagellar genes and recruits RNA polymerase to express flagellar genes. When *Salmonella* enters the host cell, the expression of STM1697 is stimulated by some unknown mechanism. STM1697 then binds to the peripheral FlhD of the FlhD~4~C~2~ complex, which restrains the recruitment of RNA polymerase by steric exclusion. As a result, the expression of flagellar genes is repressed, and then the expression of FliZ-regulated genes is also downregulated. *Salmonella* benefits from this process to escape the host immune system.](gkx656fig8){#F8}

Model for STM1697-dependent flagellar regulation during infection {#SEC4-1}
-----------------------------------------------------------------

Before entry of host cells, the expression of STM1697 is low. FlhD~4~C~2~ complex binds to the upstream region of flagellar genes and recruits RNA polymerase to express flagellar genes. When *Salmonella* enters the host cell, the expression of STM1697 is stimulated by some unknown mechanism. STM1697 then binds to the peripheral FlhD of the FlhD~4~C~2~ complex, which restrains the recruitment of RNA polymerase, repressing the expression of flagellar genes. At the same time, the expression of FliZ-regulated genes is also downregulated.

This is an effective strategy for *Salmonella*. Flagellin is a major activator of NF-κB signaling pathways and pro-inflammatory gene activation in intestinal epithelial cells ([@B37],[@B38]). The STM1697-mediated repression of flagellin enables *Salmonella* to evade TLR5-mediated cytokine production in epithelial cells. Additionally, the reduction of flagellin allows *Salmonella* to escape induction of macrophage pyroptosis and replicate successfully within macrophages.

New insight into the mechanism of anti-FlhD~4~C~2~ factor-mediated motility control {#SEC4-2}
-----------------------------------------------------------------------------------

It is thought that anti-FlhD~4~C~2~ factors inhibit flagellar formation by disrupting the interaction between FlhD~4~C~2~ and its target DNA. In this study, a novel mechanism was discovered: STM1697 does not disrupt the interaction between FlhD~4~C~2~ and DNA but prevents FlhD~4~C~2~ from recruiting RNA polymerase. This research provides new insight into the mechanism of anti-FlhD~4~C~2~ factors and demonstrates how anti-FlhD~4~C~2~ can function even at low concentration.

Two EAL-like proteins in *Salmonella*, STM1344 and STM1697, act as anti-FlhD~4~C~2~ factors by direct interaction with FlhD. Those two proteins share low-sequence identity (\<22%). Previously, we have reported that the *E. coli* homolog of STM1344 regulates motility in a concentration-dependent manner ([@B10]). Our previous studies showed that *E. coli* YdiV formed multiple types of complexes with FlhD~4~C~2~. YdiV~1~--FlhD~4~C~2~ and YdiV~2~--FlhD~4~C~2~ can bind DNA, but YdiV~3~--FlhD~4~C~2~ and YdiV~4~--FlhD~4~C~2~ are unable to bind DNA. The third and fourth YdiV molecule altered the FlhD~4~C~2~ complex by entering the ring-like structure of FlhD~4~C~2~ between the two internal D subunits. This caused opening of the ring-like structure, eliminating DNA-binding ability. Thus, it was thought that YdiV-inhibited FlhD~4~C~2~ only at relatively high concentrations. However, based on the data in this paper, the model in which YdiV regulates flagellar production can be improved. When the intracellular concentration of YdiV is low, YdiV binds the exterior FlhD subunits to prevent FlhDC from recruiting RNA polymerase in a dynamical and reversible regulatory process. When the intracellular concentration of YdiV slowly accumulates to a certain level, YdiV then strips FlhD~4~C~2~ from DNA and facilitates ClpXP protease-mediated FlhD~4~C~2~ degradation, which is lasting and irreversible.

Why does *Salmonella* employ two similar factors to regulate FlhD~4~C~2~? {#SEC4-3}
-------------------------------------------------------------------------

The activation of *stm1344* and *stm1697* genes may be mediated by different factors sensing different signals. The AI-2 binding protein SdiA can activate the expression of *stm1344* but not *stm1697*, although the RNA binding protein CsrA (Carbon Storage Regulator A) is reported to reduce the expression of both *stm1344* and *stm1697* in *Salmonella* ([@B39]--[@B42]). We found the production of STM1344 was upregulated more than 10-fold when *Salmonella* was cultured in M9 restrictive medium, but no such changes were observed in the expression of STM1697 (unpublished data). Overall, the explanation of the activation of the *stm1697* gene after *Salmonella* enters host cells requires further investigation.

STM1344 and STM1697 function in different ways. It has reported that some anti-FlhD~4~C~2~ factors, like YdiV and FliT, promote hydrolysis by the ClpXP protease of the FlhD~4~C~2~ complex ([@B21],[@B22]). However, our unpublished data showed that the degradation of FlhD~4~C~2~ by the ClpXP protease was promoted by STM1344 but not by STM1697. Furthermore, we found that FlhD~4~C~2~ can preferentially form a complex with STM1344 and, most importantly, STM1344 could separate the STM1697--FlhD complex to form an STM1344--FlhD complex, but STM1697 cannot disrupt the STM1344--FlhD complex. All these phenomena suggest differences in the interactions of these proteins that could potentially explain differences in the regulatory mechanisms mediated by STM1344 or STM1697. More studies need to be done to determine the complete pathways to activate the expression of STM1344 and STM1697 and then inhibit flagellar genesis when *Salmonella* moves back and forth in different environments.
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